AIHW logo

METEOR logo

Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs

Site Navigation

  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources
Your session is about to end!
Your session will expire at [TIME]
Select Extend at the top right corner or you will be logged out

6.1, 6.2, 6.3 Number of PBS prescriptions dispensed for asthma medicines per 100,000 people, 2013–14

Indicator Attributes

Identifying and definitional attributes

Metadata item type:Help on this termIndicator
Indicator type:Help on this termIndicator
Short name:Help on this termAsthma medicines dispensing, 2013-14
METEOR identifier:Help on this term611645
Registration status:Help on this term

Australian Commission on Safety and Quality in Health Care, Standard 23/11/2016

National Health Performance Authority (retired), Retired 01/07/2016

Description:Help on this term

Number of prescriptions dispensed for asthma medicines per 100,000 people, age standardised. Data are disaggregated by the area in which the person lives.

Indicator set:Help on this term
Australian Atlas of Healthcare Variation

        Australian Commission on Safety and Quality in Health Care, Standard 23/11/2016

        National Health Performance Authority (retired), Retired 01/07/2016

Collection and usage attributes

Population group age from:Help on this term

3 to 19 years
20 to 44 years
45 years and over

Computation description:Help on this term

 

Presented as a number per 100,000 people, age standardised, by Statistical Area Level 3.

Analysis by Statistical Area Level 3 (SA3) is based on postcode of usual residence of the patient which is based on the patient's Medicare enrolment postcode on the date the prescription was dispensed.

SA3s where the total population was less than 2,500 or where the population of interest was less than 200 are excluded.

Suppression protocol for calculating age standardised rates:

 

NumeratorTotal prescriptions dispensed were less than 20 (unrounded data)
DenominatorERP for one or more five year age groups was less than 30

For the population group 3 to 19 years, the following age groups were used for calculating age standardised rates: 3-9, 10-14, 15-19.

Computation:Help on this term

100,000 x (Numerator ÷ Denominator), age standardised

For more information about age-standardisation, see

/content/index.phtml/itemId/327276

Numerator:Help on this term

Number of PBS prescriptions dispensed for asthma medicines in 2013-14.

Numerator data elements:Help on this term
Data Element / Data Set

Pharmaceutical Benefits Scheme (PBS) prescription—PBS item prescribed, code NN[NNN]A

NMDS / DSSHelp on this term

Pharmaceutical Benefits Scheme (PBS) state/territory data extract 2013-14

Guide for useHelp on this term

Data source type: Administrative by-product data

 

PBS codeDescription
01034KTERBUTALINE–Injection containing terbutaline sulfate 500 micrograms in 1 mL
01099WSALBUTAMOL–Capsule containing powder for oral inhalation 200 micrograms (as sulfate) (for use in Ventolin Rotahaler)
01103CSALBUTAMOL–Oral solution 2 mg (as sulfate) per 5 mL, 150 mL
01252XTERBUTALINE–Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 200 doses
01542EIPRATROPIUM–Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30
02000GSALBUTAMOL–Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
02001HSALBUTAMOL–Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30
02003KSALBUTAMOL–Nebuliser solution 5 mg (as sulfate) per mL, 30 mL
02065QBUDESONIDE–Nebuliser suspension 500 micrograms in 2 mL single dose units, 30
02066RBUDESONIDE–Nebuliser suspension 1 mg in 2 mL single dose units, 30
02070YBUDESONIDE–Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses
02071BBUDESONIDE–Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses
02072CBUDESONIDE–Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses
02614NTHEOPHYLLINE–Oral solution 133.3 mg per 25 mL, 500 mL
02634PTHEOPHYLLINE–Tablet 250 mg (sustained release)
02817GTERBUTALINE–Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 100 doses
02827TFLUTICASONE + EFORMOTEROL–Pressurised inhalation containing fluticasone propionate 50 micrograms with eformoterol fumarate dihydrate 5 micrograms per dose, 120 doses
02866WBUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses, 2
02867XBUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 50 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses, 2
02878LCROMOGLYCATE–Capsule containing powder for oral inhalation containing sodium cromoglycate 20 mg (for use in Intal Spinhaler or Intal Halermatic)
02938PBUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 100 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses, 2
03491RTERBUTALINE–Injection containing terbutaline sulfate 500 micrograms in 1 mL
03495YSALBUTAMOL–Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
03496BSALBUTAMOL–Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

03497C

SALBUTAMOL–Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

05134F

INDACATEROL–Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler)
05137JINDACATEROL–Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler)
08136FEFORMOTEROL–Capsule containing powder for oral inhalation containing eformoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer)
08141LSALMETEROL–Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses
08147TFLUTICASONE–Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses
08148WFLUTICASONE–Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses
08149XFLUTICASONE–Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses
08230ETHEOPHYLLINE–Tablet 200 mg (sustained release)
08231FTHEOPHYLLINE–Tablet 300 mg (sustained release)
08238NIPRATROPIUM–Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30
08239PEFORMOTEROL–Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 6 micrograms per dose, 60 doses
08240QEFORMOTEROL–Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses
08288FSALBUTAMOL–Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
08334PCROMOGLYCATE–Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC-free formulation)
08345FFLUTICASONE–Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation)
08346GFLUTICASONE–Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation)
08354QSALBUTAMOL–Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
08365GNEDOCROMIL–Pressurised inhalation containing nedocromil sodium 2 mg per dose, 112 doses (CFC-free formulation)
08406KBECLOMETHASONE–Pressurised inhalation containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation)
08407LBECLOMETHASONE–Pressurised inhalation containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation)
08408MBECLOMETHASONE–Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation)
08409NBECLOMETHASONE–Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation)
08430QFLUTICASONE + SALMETEROL–Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
08431RFLUTICASONE + SALMETEROL–Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
08432TFLUTICASONE + SALMETEROL–Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
08516FFLUTICASONE–Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation)
08517GFLUTICASONE + SALMETEROL–Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)
08518HFLUTICASONE + SALMETEROL–Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)
08519JFLUTICASONE + SALMETEROL–Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)
08625YBUDESONIDE + EFORMOTEROL–Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses
08627CMONTELUKAST–Tablet, chewable, 4 mg (as sodium)
08628DMONTELUKAST–Tablet, chewable, 5 mg (as sodium)
08671JIPRATROPIUM–Pressurised inhalation containing ipratropium bromide 21 micrograms per dose, 200 doses (CFC-free formulation)
08750MBUDESONIDE + EFORMOTEROL–Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2
08767KCROMOGLYCATE–Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC-free formulation)
08796YBUDESONIDE + EFORMOTEROL–Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses
08853YCICLESONIDE–Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation)
08854BCICLESONIDE–Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation)
09745XOMALIZUMAB–Powder for injection 150 mg with diluent
09746YOMALIZUMAB–Powder for injection 150 mg with diluent
10007QFLUTICASONE + EFORMOTEROL–Pressurised inhalation containing fluticasone propionate 125 micrograms with eformoterol fumarate dihydrate 5 micrograms per dose, 120 doses
10008RFLUTICASONE + EFORMOTEROL–Pressurised inhalation containing fluticasone propionate 250 micrograms with eformoterol fumarate dihydrate 10 micrograms per dose, 120 doses
10015DBUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 100 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses
10018GBUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses
10024NBUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 50 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses
10059KGLYCOPYRRONIUM–Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler)

Denominator:Help on this term

Total population of age group

Denominator data elements:Help on this term
Data Element / Data Set

Person—estimated resident population of Australia, total people N[N(7)]

Data SourceHelp on this term

ABS Estimated resident population (total population)

Guide for useHelp on this term

ABS Estimated resident population as at June 2001

Data source type: Census based plus administrative by-product data

Disaggregation:Help on this term

Statistical Area Level 3, which have been derived from Postcode—Australian (person): 

  • Statistical Area Level 3 (SA3s) are geographic areas defined in the ABS Australian Statistical Geography Standard (ASGS). The aim of SA3s is to create a standard framework for the analysis of ABS data at the regional level through clustering groups of SA2s that have similar regional characteristics. There are 333 spatial SA3s covering the whole of Australia without gaps or overlaps. They are designed to provide a regional breakdown of Australia. SA3s generally have a population of between 30,000 and 130,000 people. There are approximately 50 with fewer than 30,000 people and 35 with more than 130,000 as at 30 June 2011. For further information see the ABS publication, Australian Statistical Geography Standard (ASGS): Volume 1 – Main Structure and Greater Capital City Statistical Areas, July 2011 (cat. no. 1270.0.55.001).
Disaggregation data elements:Help on this term
Data Element / Data Set

Person—age, total years N[NN]

NMDS / DSSHelp on this term

COMPLETE - Pharmaceutical Benefits Scheme (PBS) Pharmacy claim script detail

Guide for useHelp on this term

Age of the person is based on the patient's Medicare enrolment date of birth and the date the prescription was dispensed.

Data is disaggregated by the following age groups:

  • 3 to 19 years
  • 20 to 44 years
  • 45 and over.

Data Element / Data Set

Address—Australian postcode, Australian postcode code (Postcode datafile) {NNNN}

NMDS / DSSHelp on this term

COMPLETE - Pharmaceutical Benefits Scheme (PBS) Pharmacy claim script detail

Guide for useHelp on this term

Postcode is based on the patient's Medicare enrolement postcode on the date the prescription was dispensed.

GPO postcodes 2001, 2124, 3001, 4001, 5001, 6843 excluded from the SA3 analysis but included in state/territory and national level analysis.

Data source type: Administrative by-product data

Used for disaggregation by Statistical Area Level 3.

Data Element / Data Set

Address—statistical area, level 3 (SA3) code (ASGS 2011) NNNNN

Representational attributes

Representation class:Help on this termRate
Data type:Help on this termInteger
Unit of measure:Help on this termService event
Format:Help on this term

NN[NNNN]

Data source attributes

Data sources:Help on this term
Data Source

ABS Estimated resident population (total population)

Frequency

Quarterly

Data quality statement

ABS Estimated resident population (total population), QS

Data custodian

Australian Bureau of Statistics

Accountability attributes

Reporting requirements:Help on this term

Australian Commission of Safety and Quality in Health Care's Atlas of Healthcare Variation, released November 2015

Organisation responsible for providing data:Help on this term

Department of Health

Accountability:Help on this term

Australian Commission of Safety and Quality in Health Care

Source and reference attributes

Submitting organisation:Help on this term

National Health Performance Authority

<Title>

<body>
<footer>

View

  • Print view

Download

  • Word
  • PDF
  • Advanced options

Review

  • Compare items
Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

Terms & Conditions
Do you agree with the Terms and Conditions?

<Title>

<body>
<footer>
Loading...

Navigation

  • Find metadata
  • Metadata management
  • How to use METEOR
  • Learn about metadata

Resources

  • Accessibility
  • Copyright
  • Disclaimer
  • Freedom of Information
  • Privacy policy
  • Vulnerability and disclosure policy

Quick Links

  • Contact
  • FAQs
  • Search
AIHW logo
© Australian Insitute of Health and Welfware, 2023